Core Laboratories (CLB) Total Liabilities (2022 - 2026)

Core Laboratories has reported Total Liabilities for 5 years, with the latest figure at $318.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 4.05% year-over-year to $318.8 million; the trailing twelve-month figure through Mar 2026 stood at $318.8 million (down 4.05% YoY), and the FY2025 full-year result was $318.0 million, down 4.44% from the prior year.
• Total Liabilities for Q1 2026 stood at $318.8 million, roughly flat from $318.0 million in the prior quarter.
• The five-year high for Total Liabilities was $403.8 million in Q2 2022, with the low at $314.0 million in Q3 2025.
• Historically, Total Liabilities has averaged $355.8 million across 5 years, with a median of $356.2 million in 2024.
• Annual changes were most pronounced in 2025 — Total Liabilities fell 8.74% — and 2026, when it dropped 4.05%.
• Core Laboratories' Total Liabilities stood at $394.8 million in 2022, then slipped by 8.31% to $362.0 million in 2023, then slipped by 8.06% to $332.8 million in 2024, then fell by 4.44% to $318.0 million in 2025, then increased by 0.26% to $318.8 million in 2026.
• The last three Total Liabilities figures came in at $318.8 million (Q1 2026), $318.0 million (Q4 2025), and $314.0 million (Q3 2025), per Business Quant data.